Summary
Human meninges and 29 meningiomas were analyzed as to their glycosphingolipid composition. In the neutral fraction GSL, a mostly even distribution of mono-, di-, tri-and tetrahexoside was demonstrated. In the group of the gangliosides, Glac 1 in one broad band in chromatogramms occurred in almost all meningiomas; Glac 2 was present in 84% of tumours. Members of the Gtri-family were only found in a small minority of tumours while various Gtet-gangliosides were detectable in nearly half of them. No constant pattern or patterns emerged and no correlation to either morphological subtype or malignancy grade could be established. Immunohistochemistry revealed focal presence of Glac 2 in a pattern similar to that of vimentin expression. Semiquantitative evaluation showed good correlation between both parameters.
Similar content being viewed by others
Abbreviations
- WHO:
-
World Health Organization
- GSL:
-
Glycosphingolipids
- aGSL:
-
acidic GSL
- nGSL:
-
neutral GSL
- For Gangliosides:
-
G stands for ganglioside, the index denominates the sugar complex (lac=lactose, tri=triaose, tet=tetraose) and the following cipher denotes the number of sialic acids. The Svennerholm notation (1963) is sometimes given in brackets. Glac1=GM3, Glac2=GD3, Gtri1=GM2, Gtri2=GD2, Gtet1=GM1, Gtet2a=GD1 a and so on.
- CMH:
-
Ceramid monohexoside
- CDH:
-
Ceramid dihexoside
- CTH:
-
Ceramid trihexoside
- CTetH:
-
Ceramid tetrahexoside
References
Berra B, Gaini SM, Riboni L (1985) Correlation between ganglioside distribution and histological grading of human astrocytomas. Int J Cancer 36: 363–366
Berra B, Riboni L, De Gasperi R, Gaini SM, Ragnotti G (1983) Modifications of ganglioside patterns in human meningiomas. J Neurochem 40, 3: 777–782
Bigner SH, Vogelstein B (1991) Cytogenetics and molecular genetics of malignant gliomas and medulloblastomas. Brain Pathology 1: 12–18
Bosslet K, Mennel HD, Rodden F, Bauer BL, Wagner F, Altmannsberger A, Sedlacek HH, Wiegandt H (1989) Monoclonal antibodies against epitopes of ganglioside GD 2 and its lactones. Markers for gliomas and neuroblastomas. Cancer Immunol Immunother 29: 171–178
Cervos-Navarro J, Vasquez J (1966) An electron microscopic study of meningiomas. Acta Neuropathol 13: 301–323
Collins VP, Nordenskjöld M, Dumanski JP (1990) The molecular genetics of meningiomas. Brain Pathology 1: 19–24
Cushing H (1922) The meningiomas (dural endotheliomas). Their source and favoured seats of origine. Brain 45: 282–316
Cushing H, Eisenhardt L (1938) Meningiomas, their classification, regional behaviour, life history and surgical results. Thomas, Springfield
Davidson P, Fredman P, Collins VP, v. Holst H, Mänsson JE, Svennerholm L (1989) Ganglioside composition in human meningiomas. J Neurochem 53(3): 705–709
Eto Y, Shinoda S (1982) Gangliosides and neutral Glykosphingolipids in human brain tumours: specifity and their significance. Adv Exp Med Biol 152: 279–290
Fredman P, Dumanski J, Davidsson P, Svennerhom L, Collins VP (1990) Expression of the gangliosdie GD3 in human meningiomas is associated with monosomy of chromosome 22. J Neurochem 27(3): 1838–1840
Gonatas NK, Besen M. An electron microscopic study of three human psammomatous meningiomas. J Neuropathol Exp Neurol 22: 263–273
Jennemann R, Rodden F, Bauer BL, Mennel HD, Wiegandt H (1990) Glykosphmgolipids of human gliomas. Cancer Res 50: 7444–7449
Kepes JJ (1982) Meningiomas: Biology, Pathology and differential diagnosis. Masson, New York Paris
Kepes JJ (1986) Presidential address: The histopathology of meningiomas, a reflection of origins and expected behaviour? J Neuropathol Exp Neurol 45: 285–303
Kostic D, Buchheit F (1970) Gangliosides in human brain tumours. Life Sci 9: 589–596
Lauterbeck L, Schwechheimer K, Moll R, Franke WW (1984) Attachment of vimentin filaments and desmosomal plaques in human meningiomal cells and arachnoidal tissue. J Cell Biol 98: 1072
Mennel HD, Plate K (1991) Morphologie und Prognose bei intrakraniellen Tumoren. Fortschr Neurol Psychiat 59: 35–42
Mennel HD, Wiegandt H, Bauer BL, Jennemann R, Rodden AF, Schachenmayr W (1991) Tissue architecture and glycosphingolipid content in human gliomas II–IV. Path Res Pract 187: 157–165
Mennel HD, Zinngrebe J, Berweiler-Nippert U, Lorenz H (1988) Meningiomas: Histogenesis and classification. Zentralbl Allg Pathol 134: 27–40
Nagle RB, McDaniel KM, Clark VA, Payne CM The use of antikeratin antibodies in the diagnosis of human neoplasm. Am J Clin Pathol 79: 458
Raimondi AJ, Mullan S, Evans JP (1962) Human brain tumours: an electron microscopic study. J Neurosurg 19: 731–753
Rodden FA, Wiegandt H, Bauer BL (1991) Gangliosides: the relevance of current research to neurosurgery. J Neurosurg 74: 606–619
Sunder-Plassmann M, Bernheimer H (1974) Ganglioside in Meningeomen und Hirnhäuten. Acta Neuropathol 27: 289–297
Wiegandt H (1985) Gangliosides. In: Wiegandt H (ed) Glycolipids. New Comprehensive Biochem, Vol 10, pp 199–260
WHO: Histological typing of tumours of the central nervous system (1979) Geneva
Zankl H, Zang KD (1980) Correlations between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1: 351–356
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pausch, G., Jennemann, R., Mennel, H.D. et al. Gangliosides in meningiomas: Correlation of Glac 2 to intermediary filament. Acta neurochir 117, 166–171 (1992). https://doi.org/10.1007/BF01400615
Issue Date:
DOI: https://doi.org/10.1007/BF01400615